8-K filing — SkinHealth Systems Inc. (SKIN)
Filed: 2026-10-06 AccNo: 0001628280-26-065232 Size: 177 KB Item 1.02: Termination of a Material Definitive Agreement Item 7.01: Regulation FD Disclosure
Stocks · News reference
TD Cowen analyst Oliver Chen maintains SkinHealth Systems (NASDAQ:SKIN) with a Hold and lowers the price target from $1 to $0.9.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Filed: 2026-10-06 AccNo: 0001628280-26-065232 Size: 177 KB Item 1.02: Termination of a Material Definitive Agreement Item 7.01: Regulation FD Disclosure
SkinHealth Systems announced the launch of HydraClear Treatment Booster, a triple-acid formula designed to clarify and balance blemish-prone skin. Clinical trials showed a 38% mean reduction in total blemishes after four treatments, with 81% of participants showing fewer visible blemishes. The product will be integrated into Deluxe and Platinum Hydrafacial treatments.
SkinHealth Systems announced the European expansion of its SkinStylus SteriLock MicroSystem, a professional microneedling and nano-needling device, now available in the UK, Ireland, Germany, France, Spain, and Portugal. The company will leverage Hydrafacial's established European distribution network to market the complementary technology to aesthetic professionals, supporting its strategy to build a broader medical aesthetics ecosystem.
SkinHealth Systems announced the European expansion of its SkinStylus SteriLock MicroSystem, a professional microneedling and nano-needling device, across the UK, Ireland, Germany, France, Spain and Portugal. The company will leverage its established Hydrafacial commercial organization and provider relationships to introduce the complementary technology to aesthetic professionals in the region.